The Effect of Head Massage Therapy on the Regulation of the Autonomic Nervous System
Head Massage Intervention to Decrease Physiological Signs of Stress as Assessed by Changes in the Autonomic Nervous System Functions in Healthy Volunteers: A Pilot Study
1 other identifier
interventional
10
1 country
1
Brief Summary
The autonomic nervous system (ANS) unconsciously regulates the activities of vital organ systems such as the respiratory, circulatory, and urinary systems. It consists of two major components, the parasympathetic nervous system (PNS) and the sympathetic nervous system (SNS), which together are in charge of keeping our body in homeostasis. Homeostasis is the state of chemical and metabolic balance within an organism; it is disturbed in situations of uncontrolled stress. Massage has been shown to decrease SNS and stimulate PNS; but most studies focused on full body massage, with limited assessment of ANS function, and lacked control groups. The effects of head massage therapy (HMT) on regulating the activity of the ANS have not been studied before. In this pilot study, we propose that by randomizing 10 participants to sessions of HMT and 'Simple Relaxation' (no HMT), and by using a non-invasive method of measuring the ANS activity (spectral analysis of Heart Rate Variability \[HRV\] as well as Pre-ejection Period (PEP)), we will be able to investigate the effects of 10 minutes of HMT in comparison with the period of no HMT administered. We expect HMT to reduce stress, with a better and balanced profile of autonomic nervous system after receiving massage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 9, 2014
CompletedFirst Posted
Study publicly available on registry
August 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedMay 28, 2015
May 1, 2015
5 months
August 9, 2014
May 26, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Heart Rate Variability (HRV) parameters
Main HRV parameters that will be reported include High Frequency (HF) which is the power in high frequency range representative of the parasympathetic nervous system activity, HFnu which is the HF power in normalized units, and total power which is the total variability of the autonomic nervous system over the temporal segment. HRV parameters are measured at baseline and post intervention. Post-intervention outcomes for each subject will be compared with their baseline. There will also be comparison of the outcomes between the massage and the control intervention, for the effect of massage therapy
Within 1 day
Pre-ejection period (PEP)
PEP is the time interval between electrical stimulation of the sinoatrial node and opening of the aortic valves and has shown to be inversely correlated with the activity of the sympathetic nervous system. PEP is measured at baseline and post intervention. Post-intervention outcomes for each subject will be compared with their baseline. There will also be comparison of the outcomes between the massage and the control intervention, for the effect of massage therapy.
Within 1 day
Interventions
Intervention consists of administering head massage therapy according to the Chinese head massage protocol for approximately 10 minutes.
Consists of a simple relaxation in the same sitting position as the head massage therapy session.
Eligibility Criteria
You may qualify if:
- Otherwise healthy individuals
You may not qualify if:
- Use of anti-depressants or drugs that affect the cardiovascular system or ANS
- Smoking more than 10 cigarettes/day
- Inability to provide consent
- Inability to speak and/or understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BC Children's and Women's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Paul Collet, MD, PhD
Children's & Women's Health Centre of British Columbia
- PRINCIPAL INVESTIGATOR
Mir Sohail Fazeli, M.D.
The University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 9, 2014
First Posted
August 13, 2014
Study Start
April 1, 2014
Primary Completion
September 1, 2014
Last Updated
May 28, 2015
Record last verified: 2015-05